drugset / Trial / NCT05480553
NPC-06 to Pain Associated With Acute Herpes Zoster
RandomizedParallel-groupDouble-blindTreatment
Summary
To confirm the pain relief effect and the safety of NPC-06 (fosphenytoin sodium hydrate) in patients with pain associated with acute herpes zoster in a placebo-controlled, double-blind, parallel-group, comparative manner.
Timeline
- Start
- 2022-08-05
- Primary completion
- 2023-05-29
- Completion
- 2023-08-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NPC-06 | Unknown | 7.5 mg/kg | Intravenous |